[1] Kwon Y,Koene RJ,Kwon O,et al.Effect of sleep-disordered breathing on appropriate implantable cardioverter-defibrillator therapy in patients with heart failure:a systematic review and meta-analysis[J].Circ Arrhythm Electrophysiol,2017,10(2):4609~4610. [2] Wu P,Zhai Y,Li D,et al.The function and significance of SERA2a in congestive heart failure:an analysis of gene therapy trials[J].Histol Histopathol,2017,10(146):875~878. [3] 罗玉钊,陈炎,何洪,等.胺碘酮治疗充血性心力衰竭合并室性心律失常的效果[J].中国医药导报,2015,12(8):57~60. [4] 任古松,张春霞.卡维地洛治疗老年慢性充血性心衰合并快速型心律失常60例疗效观察[J].山东医药,2013,53(25):103~104. [5] 赵云泉.厄贝沙坦配合美托洛尔对充血性心衰合并室性心律失常的治疗作用[J].中国现代药物应用,2011,5(23):7~8. [6] Lelakowski J,Rydlewska A,Lelakowska M,et al.The evaluation of the ventricular arrhythmias and interventions of cardiac implantable electronic devices in patients with dilated cardiomyopathy for primary prevention of sudden cardiac death in ambulatory and telemetric follow-up[J].Pol Merkur Lekarski,2017,42(247):13~20. [7] Botto GL,Padeletti L,Covino G,et al.Electrical treatment of atrial arrhythmias in heart failure patients implanted with a dual defibrillator CRT device.Results from the TRADE-HF study[J].Int Cardiol,2017,5273(16):33105~33109. [8] 罗玉钊,陈炎,何洪,等.胺碘酮治疗充血性心力衰竭合并室性心律失常的效果[J].中国医药导报,2015,12(8):57~60. [9] 焦方晓.厄贝沙坦联合胺碘酮治疗充血性心力衰竭并快速室性心律失常的效果[J].包头医学院学报,2016,32(6):81~82. [10] Biering-Srensen T,Knappe D,Pouleur AC,et al.Regional longitudinal deformation improves prediction of ventricular tachyarrhythmias in patients with heart failure with reduced ejection fraction:a MADIT-CRT substudy (multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy)[J].Circ Cardiovasc Imaging,2017,10(1):5096~5097. [11] 徐爱国.厄贝沙坦配合美托洛尔对充血性心衰合并室性心律失常的治疗作用分析[J].中西医结合心血管病电子杂志,2016,4(15):7. [12] 时占楼.比索洛尔联合曲美他嗪治疗冠心病合并充血性心力衰竭[J].贵阳医学院学报,2014,39(2):245~246. [13] 孔丽凤,李敏.厄贝沙坦配合美托洛尔对充血性心衰合并室性心律失常的治疗作用分析[J].中国继续医学教育,2016,8(8):145~146. [14] 白润爱,何勇.胺碘酮联合厄贝沙坦对充血性心力衰竭并室性心律失常的疗效观察[J].中国循证心血管医学杂志,2016,8(2):180~182. [15] 吴礼泓,雷英,胡东升,等.胺碘酮和比索洛尔治疗充血性心力衰竭并室性心律失常的疗效观察[J].新疆医学,2012,42(6):33~35. |